Abstract G-protein-coupled receptors (GPCRs) are currently one of the largest families of drug targets. The constitutive activation induced by mutation of key GPCR residues is associated closely with various diseases. However, the structural basis underlying such activation and its role in drug binding has remained unclear. Herein, we used all-atom molecular dynamics simulations and free energy calculations to study the effects of a D130N mutation on the structure of β2 adrenergic receptor (β2AR) and its binding of the agonist salbutamol. The results indicate that the mutation caused significant changes in some key helices. In particular, the mutation leads to the departure of transmembrane 3 (TM3) from transmembrane 6 (TM6) and marked changes in the NPxxY region as well as the complete disruption of a key ionic lock, all of which contribute to the observed constitutive activation. In addition, the D130N mutation weakens some important H-bonds, leading to structural changes in these regions. Binding free energy calculations indicate that van der Waals and electrostatic interactions are the main driving forces in binding salbutamol; however, binding strength in the mutant β2AR is significantly enhanced mainly through modifying electrostatic interactions. Further analysis revealed that the increase in binding energy upon mutation stems mainly from the H-bonds formed between the hydroxyl group of salbutamol and the serine residues of TM5. This observation suggests that modifications of the H-bond groups of this drug could significantly influence drug efficacy in the treatment of diseases associated with this mutation. Graphical abstractAll-atom molecular dynamics simulation and free energy calculations were used to study the effects of the D130N mutation on the structure of β2 adrenergic receptor (β2AR) and its binding with salbutamol agonist. The results indicate that the mutation induces significant changes in some important regions and favors agonist binding mainly through increasing non-bond electrostatic interactions
molecular dynamics  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

H-bond                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

lock                          0.9833883310694821^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lock_(computer_science)

agonist                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Agonist               

transmembrane                 0.7179970203741745^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_membrane         

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

binding energy                0.9999585641523191^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Binding_energy        

G-protein-coupled receptors   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/G_protein-coupled_receptor

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

simulation                    0.8309836285475354^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computer_simulation   

salbutamol                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Salbutamol            

H-bonds                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

agonist                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Agonist               

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

salbutamol                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Salbutamol            

adrenergic receptor           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Adrenergic_receptor   

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

adrenergic receptor           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Adrenergic_receptor   

salbutamol                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Salbutamol            

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

transmembrane                 0.7179970203741745^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_membrane         

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

serine                        0.9999999999982947^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Serine                

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

mutant                        0.9999997990061249^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

electrostatic interactions    0.9999907037681716^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

salbutamol                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Salbutamol            

electrostatic interactions    0.9999907037681716^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

GPCR                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/G_protein-coupled_receptor

electrostatic interactions    0.9999907037681716^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

agonist                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Agonist               

van der Waals                 0.9999999999969305^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Van_der_Waals_force   

mutation                      0.9999999999995453^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mutation              

H-bonds                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

hydroxyl group                0.9999999999824922^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hydroxyl              

